The experimental vaccine developed in Hong Kong CanSino Biologics Inc. and the Beijing Institute of Biotechnology is the furthest in the clinical process. It is in the second stage of testing.
Another two vaccines are tested on people in the U.S. The vaccines are developed by American pharmacists Moderna Inc and Inovio Pharmaceuticals Inc.
Moreover, the vaccine developed in China is approved for testing on people in the epicenter of the spread of coronavirus infection.
“Progress is occurring at unprecedented speed in developing vaccines as the infectious pathogen looks unlikely to be stamped out through containment measures alone,” the message said.
It is noted that the drug industry hopes to reduce the time required for placing the vaccine to a market from the usual 10-15 years to the next year.
Besides, CanSino Biologics Inc. earlier stated about the approval of the Chinese regulation body concerning the test of the vaccine on people. Moderna company from Cambridge, Massachusetts, which has never issued the product, got the approval of the regulatory body for the rapid transition to the test on people in March, skipping years of testing on animals, which is a norm during the development of the vaccines. Inovio started its tests on people last week.
Meanwhile, in Ukraine, the number of coronavirus cases has increased by 270: the total number of infected persons is 3,372.